Literature DB >> 3740719

Audiologic findings in young patients with hypophosphatemic bone disease.

M Meister, A Johnson, G R Popelka, G S Kim, M P Whyte.   

Abstract

Audiometric tests were conducted on 19 subjects with hypophosphatemic bone disease to investigate whether auditory impairment like that reported in affected adults occurs in young patients. No hearing loss or significant auditory findings were noted among the children or young adult patients. However, sensorineural hearing loss of cochlear origin was identified in the three oldest subjects (40 to 58 years), although a history of noise exposure in two of them could explain the observations. The results indicate that if an association exists between hypophosphatemic bone disease and hearing impairment, the auditory signs will not develop until adulthood in treated patients. Additional studies of large populations of affected adults are needed to identify the incidence and mechanism(s) of the auditory system abnormalities and to assess any effect of medical therapy for the metabolic bone disease.

Entities:  

Mesh:

Year:  1986        PMID: 3740719     DOI: 10.1177/000348948609500418

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  6 in total

Review 1.  Hearing impairment in familial X-linked hypophosphatemic rickets.

Authors:  Gadi Fishman; Denise Miller-Hansen; Cynthia Jacobsen; Virender K Singhal; Uri S Alon
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

2.  A novel auditory ossicles membrane and the development of conductive hearing loss in Dmp1-null mice.

Authors:  Kun Lv; Haiyang Huang; Xing Yi; Mark E Chertoff; Chaoyuan Li; Baozhi Yuan; Robert J Hinton; Jian Q Feng
Journal:  Bone       Date:  2017-06-08       Impact factor: 4.398

Review 3.  Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.

Authors:  Andrea Trombetti; Nasser Al-Daghri; Maria Luisa Brandi; Jorge B Cannata-Andía; Etienne Cavalier; Manju Chandran; Catherine Chaussain; Lucia Cipullo; Cyrus Cooper; Dieter Haffner; Pol Harvengt; Nicholas C Harvey; Muhammad Kassim Javaid; Famida Jiwa; John A Kanis; Andrea Laslop; Michaël R Laurent; Agnès Linglart; Andréa Marques; Gabriel T Mindler; Salvatore Minisola; María Concepción Prieto Yerro; Mario Miguel Rosa; Lothar Seefried; Mila Vlaskovska; María Belén Zanchetta; René Rizzoli
Journal:  Nat Rev Endocrinol       Date:  2022-04-28       Impact factor: 43.330

4.  Characterization of hearing-impairment in Generalized Arterial Calcification of Infancy (GACI).

Authors:  Elizabeth H Theng; Carmen C Brewer; Ralf Oheim; Christopher K Zalewski; Kelly A King; Maximillian M Delsmann; Tim Rolvien; Rachel I Gafni; Demetrios T Braddock; H Jeffrey Kim; Carlos R Ferreira
Journal:  Orphanet J Rare Dis       Date:  2022-07-19       Impact factor: 4.303

Review 5.  FGF23 and its role in X-linked hypophosphatemia-related morbidity.

Authors:  Signe Sparre Beck-Nielsen; Zulf Mughal; Dieter Haffner; Ola Nilsson; Elena Levtchenko; Gema Ariceta; Carmen de Lucas Collantes; Dirk Schnabel; Ravi Jandhyala; Outi Mäkitie
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

6.  Therapeutic management of hypophosphatemic rickets from infancy to adulthood.

Authors:  Agnès Linglart; Martin Biosse-Duplan; Karine Briot; Catherine Chaussain; Laure Esterle; Séverine Guillaume-Czitrom; Peter Kamenicky; Jerome Nevoux; Dominique Prié; Anya Rothenbuhler; Philippe Wicart; Pol Harvengt
Journal:  Endocr Connect       Date:  2014-03-14       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.